Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices
Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices
$4,750.00
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for PVD therapeutic devices; these include percutaneous transluminal angioplasty devices, vascular stents, atherectomy devices, thrombectomy devices, and chronic total occlusion crossing devices.
Publisher: Meddevicetracker
- Description
- Contents
Overview
The 2019 combined global prevalence of peripheral vascular disease (PVD) was more than 113 million, with an incidence of 10.5 million and over 74,000 related deaths. Global sales of PVD therapeutic devices were estimated at $5.3bn in 2021. Market drivers include the increasing elderly population and its associated increase in PVD prevalence, a growing preference for minimally invasive therapies, and a preference for technologies that reduce healthcare costs and reduce hospital lengths of stay. Limiters to this market include device cost, lack of routine screening for PVD, regulatory barriers to market entry, and the threat of ongoing COVID-19 restrictions and supply chain issues worldwide.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for PVD therapeutic devices; these include percutaneous transluminal angioplasty devices, vascular stents, atherectomy devices, thrombectomy devices, and chronic total occlusion crossing devices. Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2021–26.
The report provides the following useful information:
- epidemiology of PVD
- key statistics on selected PVD in major regions in the world
- medical device product portfolio overviews, by manufacturer
- insight into developing and potentially disruptive technologies
- in-depth market and competitive analysis.
Table of Contents
Executive Summary …………………………………………………………………….. ES-1
i. Peripheral vascular disease overview …………………………………………………………………. ES-1
ii. Global peripheral vascular disease therapeutic devices market ……………………………… ES-1
a. Market drivers and limiters…………………………………………………………………… ES-4
b. Device segment insights ………………………………………………………………………. ES-6
c. Technology trends ………………………………………………………………………………. ES-6
d. Market leaders…………………………………………………………………………………… ES-6
e. Competitive strategies…………………………………………………………………………. ES-7
f. Emerging competition ………………………………………………………………………….. ES-7
iii. Methodology………………………………………………………………………………………………… ES-8
iv. Bibliography …………………………………………………………………………………………………. ES-9
Exhibit ES-1: Peripheral vascular disease therapeutic devices, combined market forecast, by country/region ($m), 2021–26 ……………………………………………………………… ES-3
Exhibit ES-2: Peripheral vascular disease therapeutic devices market, share by country/region, 2021………………………………………………………………….. ES-4
Exhibit ES-3: Market drivers and limiters……………………………………………………………….. ES-5
1. Peripheral Vascular Disease Overview ……………………………………………1-1
1.1 Critical limb ischemia ………………………………………………………………………………………1-4
1.2 Deep vein thrombosis/pulmonary embolism……………………………………………………….1-4
1.3 Diagnosis and treatment………………………………………………………………………………….1-6
1.4 Bibliography…………………………………………………………………………………………………..1-7
Exhibit 1-1: Estimated prevalence of peripheral artery disease per 100,000 people, selected regions, 2019……………………………………………………………………………….1-3
Exhibit 1-2: Estimated incidence of deep vein thrombosis, by region, 2020 ……………………1-5
Exhibit 1-3: Estimated incidence of pulmonary embolism, by region, 2020…………………….1-6
2. Peripheral Vascular Disease Therapeutic Products ……………………………2-1
2.1 Angioplasty catheters………………………………………………………………………………………2-1
2.1.1 Balloon angioplasty products………………………………………………………………2-1
2.1.2 Drug-coated balloon catheter products…………………………………………………2-5
2.1.3 Cutting and scoring balloon catheter products……………………………………..2-10
2.2 Vascular stents……………………………………………………………………………………………..2-14
2.2.1 Bare-metal stents ……………………………………………………………………………2-14
2.2.2 Drug-eluting stents………………………………………………………………………….2-16
2.2.3 Bioabsorbable stents ……………………………………………………………………….2-18
2.3 Atherectomy catheters…………………………………………………………………………………..2-20
2.4 Thromboembolectomy catheters…………………………………………………………………….2-25
2.5 Chronic total occlusion therapy devices…………………………………………………………….2-30
2.6 Bibliography…………………………………………………………………………………………………2-36
Exhibit 2-1: Selected balloon angioplasty catheters for peripheral vascular disease, 2022 …………………………………………………………………………………………..2-3
Exhibit 2-2: Selected drug-coated balloons for peripheral vascular disease, 2022……………2-9
Exhibit 2-3: Selected cutting/scoring balloon catheters for peripheral vascular disease, 2022 …………………………………………………………………………………………2-12
Exhibit 2-4: Selected bare-metal stents for peripheral vascular disease, 2022 ………………2-15
Exhibit 2-5: Selected drug-eluting stents for peripheral vascular disease, 2022 …………….2-18
Exhibit 2-6: Selected atherectomy devices for peripheral vascular disease, 2022…………..2-23
Exhibit 2-7: Selected thrombectomy devices for peripheral vascular disease, 2022 ……….2-28
Exhibit 2-8: Selected chronic total occlusion crossing devices for peripheral vascular disease, 2022 …………………………………………………………………………………………2-33
3. Peripheral Vascular Disease Therapeutic Devices Market…………………..3-1
3.1 Global market insights……………………………………………………………………………………..3-1
3.1.1 Market value ……………………………………………………………………………………3-2
3.1.2 Technology trends …………………………………………………………………………….3-7
3.1.3 Market drivers and limiters…………………………………………………………………3-9
3.1.4 Peripheral vascular disease therapeutic devices……………………………………3-13
3.1.5 Market leaders ……………………………………………………………………………….3-19
3.1.6 Competitive strategies……………………………………………………………………..3-20
3.1.7 Emerging competition………………………………………………………………………3-20
3.2 Global competitors………………………………………………………………………………………..3-21
3.2.1 Angioplasty catheters ………………………………………………………………………3-23
3.2.2 Vascular stents ……………………………………………………………………………….3-25
3.2.3 Atherectomy catheters…………………………………………………………………….3-27
3.2.4 Thrombectomy catheters………………………………………………………………….3-29
3.2.5 CTO crossing devices………………………………………………………………………..3-30
3.3 Market forecast…………………………………………………………………………………………….3-31
3.3.1 Market analysis: US………………………………………………………………………….3-32
3.3.2 Market analysis: 5 Euro…………………………………………………………………….3-39
3.3.3 Market analysis: Japan……………………………………………………………………..3-45
3.3.4 Market analysis: RoW ………………………………………………………………………3-51
3.4 Bibliography…………………………………………………………………………………………………3-57
Exhibit 3-1: Peripheral vascular disease therapeutic devices, combined market forecast, by product segment ($m), 2021–26……………………………………………………………..3-4
Exhibit 3-2: Peripheral vascular disease therapeutic devices market, share by product segment, 2021………………………………………………………………………………………….3-5
Exhibit 3-3: Peripheral vascular disease therapeutic devices, combined market forecast, by country/region ($m), 2021–26 ………………………………………………………………..3-6
Exhibit 3-4: Peripheral vascular disease therapeutic devices market, share by country/region, 2021…………………………………………………………………………………3-7
Exhibit 3-5: Market drivers and limiters………………………………………………………………….3-13
Exhibit 3-6: Peripheral vascular disease therapeutic devices market, combined share by supplier, 2021…………………………………………………………………………………….3-23
Exhibit 3-7: Angioplasty catheters market, share by supplier, 2021 …………………………….3-25
Exhibit 3-8: Vascular stents market, share by supplier, 2021 ……………………………………..3-27
Exhibit 3-9: Atherectomy devices market, share by supplier, 2021 ……………………………..3-29
Exhibit 3-10: Thrombectomy devices market, share by supplier, 2021…………………………3-30
Exhibit 3-11: Chronic total occlusion crossing devices market, share by supplier, 2021…..3-31
Exhibit 3-12: US, peripheral vascular disease therapies, procedure volumes forecast, 2021–26……………………………………………………………………………………3-35
Exhibit 3-13: US, peripheral vascular disease therapeutic devices, combined market forecast, by product type ($m), 2021–26…………………………………………………….3-37
Exhibit 3-14: 5 Euro, peripheral vascular disease therapies, procedure volumes forecast, 2021–26 ………………………………………………………………………………………………..3-42
Exhibit 3-15: 5 Euro, peripheral vascular disease therapeutic devices, combined market forecast, by product type ($m), 2021–26…………………………………………………….3-44
Exhibit 3-16: Japan, peripheral vascular disease therapies, procedure volumes forecast, 2021–26……………………………………………………………………………………3-48
Exhibit 3-17: Japan, peripheral vascular disease therapeutic devices, combined market forecast, by product type ($m), 2021–26…………………………………………………….3-50
Exhibit 3-18: RoW, peripheral vascular disease therapeutic devices, combined market forecast, by product type ($m), 2021–26…………………………………………………….3-55
Appendix: Company Listing……………………………………………………………. A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Market Spotlight: Gout 
Sign up to the